Shares in dual-listed diagnostics company Pacific Edge have plummeted after the lifting of a trading halt imposed last Friday while the company sought advice on proposed funding reimbursement changes in the US.
The share price has dropped 41% to 46c so far in trading today, after earlier hitting a
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive offer for uni students studying at a New Zealand university (valued at $499).